Pharmaceuticals, Biotechnology and Life Sciences
— On-track to initiate Phase 2b trial in 4Q 2022, with topline data expected in 1Q 2024 —- Cash runway…
ARLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research,…
LONDON, Nov. 28, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating…
New patent granted in the United States by the USPTO covers the use of lanifibranor for the potential treatment of…
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 28, 2022 (GLOBE NEWSWIRE) —…
CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the development…
SEATTLE , Nov. 28, 2022 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted…
Woburn, Nov. 28, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (“Biofrontera” or the “Company”) (NASDAQ: BFRI), announced today that they will…
Successful completion of TSX listing reviewExpansion of adult-use portfolio into key fifth province5 provinces now selling Aleafia’s adult-use products TORONTO,…
Regulatory clearance lays key technological and regulatory foundation for BT BeaMedical’s vision of revolutionizing treatment options in neurosurgery, oncology, and…